217 related articles for article (PubMed ID: 18774127)
21. Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia.
Li XZ; Zhang L; McKay GA; Poole K
J Antimicrob Chemother; 2003 Apr; 51(4):803-11. PubMed ID: 12654758
[TBL] [Abstract][Full Text] [Related]
22. Structural and biochemical analyses of an aminoglycoside 2'-N-acetyltransferase from Mycolicibacterium smegmatis.
Jeong CS; Hwang J; Do H; Cha SS; Oh TJ; Kim HJ; Park HH; Lee JH
Sci Rep; 2020 Dec; 10(1):21503. PubMed ID: 33299080
[TBL] [Abstract][Full Text] [Related]
23. Studying modification of aminoglycoside antibiotics by resistance-causing enzymes via microarray.
Disney MD
Methods Mol Biol; 2012; 808():303-20. PubMed ID: 22057534
[TBL] [Abstract][Full Text] [Related]
24. Dynamics and quantitative contribution of the aminoglycoside 6'-
d'Udekem d'Acoz O; Hue F; Ye T; Wang L; Leroux M; Rajngewerc L; Tran T; Phan K; Ramirez MS; Reisner W; Tolmasky ME; Reyes-Lamothe R
mSphere; 2024 Mar; 9(3):e0078923. PubMed ID: 38353533
[TBL] [Abstract][Full Text] [Related]
25. Overexpression and mechanistic analysis of chromosomally encoded aminoglycoside 2'-N-acetyltransferase (AAC(2')-Ic) from Mycobacterium tuberculosis.
Hegde SS; Javid-Majd F; Blanchard JS
J Biol Chem; 2001 Dec; 276(49):45876-81. PubMed ID: 11590162
[TBL] [Abstract][Full Text] [Related]
26. Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6')-Ib.
Haldorsen BC; Simonsen GS; Sundsfjord A; Samuelsen O;
Diagn Microbiol Infect Dis; 2014 Jan; 78(1):66-9. PubMed ID: 24231381
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of a novel substrate-free form of the aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium.
Jang H; Kwon S; Jeong CS; Lee CW; Hwang J; Jung KH; Lee JH; Park HH
Acta Crystallogr F Struct Biol Commun; 2020 Aug; 76(Pt 8):364-371. PubMed ID: 32744248
[TBL] [Abstract][Full Text] [Related]
28. Genetic basis of enzymatic resistance of E. coli to aminoglycosides.
Ojdana D; Sieńko A; Sacha P; Majewski P; Wieczorek P; Wieczorek A; Tryniszewska E
Adv Med Sci; 2018 Mar; 63(1):9-13. PubMed ID: 28763677
[TBL] [Abstract][Full Text] [Related]
29. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
[TBL] [Abstract][Full Text] [Related]
30. Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?
Ho II; Chan CY; Cheng AF
Antimicrob Agents Chemother; 2000 Jan; 44(1):39-42. PubMed ID: 10602720
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant.
Vetting MW; Park CH; Hegde SS; Jacoby GA; Hooper DC; Blanchard JS
Biochemistry; 2008 Sep; 47(37):9825-35. PubMed ID: 18710261
[TBL] [Abstract][Full Text] [Related]
32. Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance.
Bastida A; Hidalgo A; Chiara JL; Torrado M; Corzana F; Pérez-Cañadillas JM; Groves P; Garcia-Junceda E; Gonzalez C; Jimenez-Barbero J; Asensio JL
J Am Chem Soc; 2006 Jan; 128(1):100-16. PubMed ID: 16390137
[TBL] [Abstract][Full Text] [Related]
33. ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin.
Bordeleau E; Stogios PJ; Evdokimova E; Koteva K; Savchenko A; Wright GD
mBio; 2021 Feb; 12(1):. PubMed ID: 33563840
[TBL] [Abstract][Full Text] [Related]
34. Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance.
Jana S; Deb JK
Curr Drug Targets; 2005 May; 6(3):353-61. PubMed ID: 15857293
[TBL] [Abstract][Full Text] [Related]
35. A Novel 6'-N-Aminoglycoside Acetyltransferase, AAC(6')-Ial, from a Clinical Isolate of Serratia marcescens.
Tada T; Miyoshi-Akiyama T; Shimada K; Dahal RK; Mishra SK; Ohara H; Kirikae T; Pokhrel BM
Microb Drug Resist; 2016 Mar; 22(2):103-8. PubMed ID: 26270859
[TBL] [Abstract][Full Text] [Related]
36. Structural elucidation of substrate-bound aminoglycoside acetyltransferase (3)-IIIa.
Zieliński M; Blanchet J; Hailemariam S; Berghuis AM
PLoS One; 2022; 17(8):e0269684. PubMed ID: 35921328
[TBL] [Abstract][Full Text] [Related]
37. The use of aminoglycoside derivatives to study the mechanism of aminoglycoside 6'-N-acetyltransferase and the role of 6'-NH2 in antibacterial activity.
Yan X; Gao F; Yotphan S; Bakirtzian P; Auclair K
Bioorg Med Chem; 2007 Apr; 15(8):2944-51. PubMed ID: 17317190
[TBL] [Abstract][Full Text] [Related]
38. Exploring the substrate promiscuity of drug-modifying enzymes for the chemoenzymatic generation of N-acylated aminoglycosides.
Green KD; Chen W; Houghton JL; Fridman M; Garneau-Tsodikova S
Chembiochem; 2010 Jan; 11(1):119-26. PubMed ID: 19899089
[TBL] [Abstract][Full Text] [Related]
39. Structural Analysis of the Tobramycin and Gentamicin Clinical Resistome Reveals Limitations for Next-generation Aminoglycoside Design.
Bassenden AV; Rodionov D; Shi K; Berghuis AM
ACS Chem Biol; 2016 May; 11(5):1339-46. PubMed ID: 26900880
[TBL] [Abstract][Full Text] [Related]
40. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
Miller GH; Sabatelli FJ; Naples L; Hare RS; Shaw KJ
J Chemother; 1995 Jun; 7 Suppl 2():31-44. PubMed ID: 8622109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
